Consonance Capital Management LP 13D and 13G filings for Sio Gene Therapies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:57 pm Sale |
2021-12-31 | 13G | Sio Gene Therapies Inc. SIOX |
Consonance Capital Management LP | 0 0.000% |
-6,058,505 (Position Closed) |
Filing |
| 2021-02-16 4:27 pm Unchanged |
2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX |
Consonance Capital Management LP | 6,058,505 9.990% |
0 (Unchanged) |
Filing |
| 2021-02-16 2:40 pm Purchase |
2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX |
Consonance Capital Management LP | 6,058,505 9.990% |
6,058,505 (New Position) |
Filing |